Company intelligence / Profile preview

セラバイオファーマ

Kyoto, Kyoto, Japan

Ownership: Private
Development stage: Other

Overview

CeraBiopharma is a Japanese clinical-stage biotechnology company focused on developing innovative therapeutics using proprietary drug delivery system (DDS) technologies. The company's core expertise lies in enhancing the bioavailability of poorly soluble compounds, specifically curcumin, to treat refractory diseases. Its lead candidate, CBP-101, is a highly bioavailable curcumin formulation currently being evaluated in Phase 2 clinical trials for pancreatic cancer. Beyond oncology, CeraBiopharma is expanding its pipeline into neurodegenerative diseases like Alzheimer's and cardiovascular conditions such as heart failure. By targeting the NF-kappaB and p300/CBP pathways, the company aims to provide new treatment options for patients with high unmet medical needs.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Small moleculeNanoparticle
Industry: Biotech

Partnerships

Theravalues Corporation

Beyond the preview

Go deeper on セラバイオファーマ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on セラバイオファーマ.

Explore the full profile